vs

Side-by-side financial comparison of DOMO, INC. (DOMO) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.

DOMO, INC. is the larger business by last-quarter revenue ($79.4M vs $75.5M, roughly 1.1× PUMA BIOTECHNOLOGY, INC.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs -0.5%). PUMA BIOTECHNOLOGY, INC. produced more free cash flow last quarter ($14.4M vs $1.1M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs -0.5%).

Domo, Inc. is an American cloud software company based in American Fork, Utah, United States. It specializes in artificial intelligence, business intelligence, and data visualization and is designed to provide real-time access to business data for decision makers across the company with minimal IT involvement. It is a Software-as-a-Service (SaaS) venture.

Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.

DOMO vs PBYI — Head-to-Head

Bigger by revenue
DOMO
DOMO
1.1× larger
DOMO
$79.4M
$75.5M
PBYI
Growing faster (revenue YoY)
PBYI
PBYI
+28.2% gap
PBYI
27.7%
-0.5%
DOMO
More free cash flow
PBYI
PBYI
$13.3M more FCF
PBYI
$14.4M
$1.1M
DOMO
Faster 2-yr revenue CAGR
PBYI
PBYI
Annualised
PBYI
31.3%
-0.5%
DOMO

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
DOMO
DOMO
PBYI
PBYI
Revenue
$79.4M
$75.5M
Net Profit
$-10.4M
Gross Margin
74.2%
69.3%
Operating Margin
-8.7%
22.7%
Net Margin
-13.1%
Revenue YoY
-0.5%
27.7%
Net Profit YoY
44.6%
EPS (diluted)
$-0.25
$0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DOMO
DOMO
PBYI
PBYI
Q4 25
$79.4M
$75.5M
Q3 25
$79.7M
$54.5M
Q2 25
$80.1M
$52.4M
Q1 25
$78.8M
$46.0M
Q4 24
$79.8M
$59.1M
Q3 24
$78.4M
$80.5M
Q2 24
$80.1M
$47.1M
Q1 24
$80.2M
$43.8M
Net Profit
DOMO
DOMO
PBYI
PBYI
Q4 25
$-10.4M
Q3 25
$-22.9M
$8.8M
Q2 25
$-18.1M
$5.9M
Q1 25
$-17.7M
$3.0M
Q4 24
$-18.8M
Q3 24
$-19.5M
$20.3M
Q2 24
$-26.0M
$-4.5M
Q1 24
$-18.7M
$-4.8M
Gross Margin
DOMO
DOMO
PBYI
PBYI
Q4 25
74.2%
69.3%
Q3 25
74.8%
77.7%
Q2 25
74.2%
76.5%
Q1 25
74.4%
77.1%
Q4 24
75.0%
76.4%
Q3 24
74.3%
63.9%
Q2 24
74.1%
77.4%
Q1 24
76.3%
75.5%
Operating Margin
DOMO
DOMO
PBYI
PBYI
Q4 25
-8.7%
22.7%
Q3 25
-9.1%
17.6%
Q2 25
-17.9%
12.7%
Q1 25
-15.6%
8.7%
Q4 24
-13.9%
22.6%
Q3 24
-18.5%
27.4%
Q2 24
-26.8%
-4.6%
Q1 24
-16.6%
-5.3%
Net Margin
DOMO
DOMO
PBYI
PBYI
Q4 25
-13.1%
Q3 25
-28.8%
16.2%
Q2 25
-22.5%
11.2%
Q1 25
-22.4%
6.5%
Q4 24
-23.5%
Q3 24
-24.9%
25.2%
Q2 24
-32.5%
-9.6%
Q1 24
-23.3%
-11.0%
EPS (diluted)
DOMO
DOMO
PBYI
PBYI
Q4 25
$-0.25
$0.26
Q3 25
$-0.56
$0.17
Q2 25
$-0.45
$0.12
Q1 25
$-0.45
$0.06
Q4 24
$-0.48
$0.40
Q3 24
$-0.51
$0.41
Q2 24
$-0.69
$-0.09
Q1 24
$-0.51
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DOMO
DOMO
PBYI
PBYI
Cash + ST InvestmentsLiquidity on hand
$97.5M
Total DebtLower is stronger
$124.2M
$22.7M
Stockholders' EquityBook value
$-191.9M
$130.3M
Total Assets
$201.6M
$216.3M
Debt / EquityLower = less leverage
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DOMO
DOMO
PBYI
PBYI
Q4 25
$97.5M
Q3 25
$94.4M
Q2 25
$47.2M
$96.0M
Q1 25
$45.3M
$93.2M
Q4 24
$101.0M
Q3 24
$96.7M
Q2 24
$61.2M
$96.8M
Q1 24
$60.9M
$107.2M
Total Debt
DOMO
DOMO
PBYI
PBYI
Q4 25
$124.2M
$22.7M
Q3 25
$121.9M
$34.0M
Q2 25
$119.7M
$45.3M
Q1 25
$117.7M
$56.7M
Q4 24
$115.6M
$68.0M
Q3 24
$115.2M
$79.3M
Q2 24
$114.1M
$90.7M
Q1 24
$113.5M
$102.0M
Stockholders' Equity
DOMO
DOMO
PBYI
PBYI
Q4 25
$-191.9M
$130.3M
Q3 25
$-191.5M
$115.3M
Q2 25
$-178.7M
$104.7M
Q1 25
$-177.2M
$97.1M
Q4 24
$-171.2M
$92.1M
Q3 24
$-166.4M
$71.1M
Q2 24
$-163.5M
$48.5M
Q1 24
$-153.5M
$51.0M
Total Assets
DOMO
DOMO
PBYI
PBYI
Q4 25
$201.6M
$216.3M
Q3 25
$195.7M
$202.9M
Q2 25
$189.7M
$194.9M
Q1 25
$214.3M
$196.2M
Q4 24
$190.2M
$213.3M
Q3 24
$197.8M
$220.7M
Q2 24
$204.4M
$205.0M
Q1 24
$225.7M
$214.1M
Debt / Equity
DOMO
DOMO
PBYI
PBYI
Q4 25
0.17×
Q3 25
0.30×
Q2 25
0.43×
Q1 25
0.58×
Q4 24
0.74×
Q3 24
1.12×
Q2 24
1.87×
Q1 24
2.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DOMO
DOMO
PBYI
PBYI
Operating Cash FlowLast quarter
$3.4M
$14.4M
Free Cash FlowOCF − Capex
$1.1M
$14.4M
FCF MarginFCF / Revenue
1.4%
19.1%
Capex IntensityCapex / Revenue
2.9%
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$9.9M
$41.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DOMO
DOMO
PBYI
PBYI
Q4 25
$3.4M
$14.4M
Q3 25
$3.4M
$9.7M
Q2 25
$4.0M
$14.1M
Q1 25
$8.9M
$3.6M
Q4 24
$-13.7M
$15.6M
Q3 24
$-6.2M
$11.0M
Q2 24
$1.9M
$1.0M
Q1 24
$5.4M
$11.2M
Free Cash Flow
DOMO
DOMO
PBYI
PBYI
Q4 25
$1.1M
$14.4M
Q3 25
$1.0M
$9.7M
Q2 25
$1.0M
$14.1M
Q1 25
$6.7M
$3.6M
Q4 24
$-16.2M
$15.6M
Q3 24
$-8.4M
$11.0M
Q2 24
$-625.0K
$1.0M
Q1 24
$2.9M
FCF Margin
DOMO
DOMO
PBYI
PBYI
Q4 25
1.4%
19.1%
Q3 25
1.3%
17.7%
Q2 25
1.3%
26.8%
Q1 25
8.5%
7.7%
Q4 24
-20.3%
26.4%
Q3 24
-10.7%
13.7%
Q2 24
-0.8%
2.1%
Q1 24
3.6%
Capex Intensity
DOMO
DOMO
PBYI
PBYI
Q4 25
2.9%
0.0%
Q3 25
2.9%
0.0%
Q2 25
3.7%
0.0%
Q1 25
2.8%
0.1%
Q4 24
3.2%
0.0%
Q3 24
2.8%
0.0%
Q2 24
3.2%
0.0%
Q1 24
3.1%
0.0%
Cash Conversion
DOMO
DOMO
PBYI
PBYI
Q4 25
Q3 25
1.10×
Q2 25
2.41×
Q1 25
1.21×
Q4 24
Q3 24
0.54×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DOMO
DOMO

Subscription$71.9M91%
Professional Servicesand Other$7.5M9%

PBYI
PBYI

Segment breakdown not available.

Related Comparisons